Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACEBRIDGE: Tapered Warfarin vs LMWH Bridging for Device Implantation
NCT02094157Phase 3Terminated
- Sponsor
- McMaster University
- Start
- Dec 2007
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of warfarin in thromboembolism (2 arms), sponsored by McMaster University. Primary endpoint: Pocket hematoma at 1 month. Started Dec 2007; status: terminated.
02
Drugs
warfarin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02094157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094157.